|
|
|
|
|
|
|
You are invited to attend an upcoming OncLive(r) webinar, to hear industry experts present their perspectives on improving clinical outcomes for patients with Metastatic NSCLC.
Check out the program agenda and click on the register button, to secure your virtual seat today. We look forward to seeing you there!
|
|
|
|
|
|
Hossein Borghaei, DO, MS
Hossein Borghaei, DO, MS
Chief, Division of Thoracic Medical Oncology
Professor, Department of Hematology/Oncology
Co-Director, Immune Monitoring Facility
Gloria and Edmund M. Dunn Chair in Thoracic Oncology
Fox Chase Cancer Center
Philadelphia, PA
|
|
|
|
|
|
Prof. Dr. Martin Reck
Head of Department Thoracic Oncology
Head of Clinical Trial Department
LungenClinic Grosshansdorf
Germany
|
|
|
|
|
Webinar Objectives:
Gain insights into factors guiding treatment selection in non-small cell lung cancer (NSCLC) lacking actionable genetic alterations Review safety and efficacy data of immune checkpoint inhibitors in first-line treatment of metastatic NSCLC Discuss treatment decision-making based on PD-L1 expression levels in NSCLC
Register Now
|
|
|
|
|
|
|
|
